PomegraUltrahuman's $70M Series C, led by Qualcomm Ventures, values the Bengaluru smart ring maker at $365M while it bets on standalone, on-device AI computing to separate itself from a crowding field.
Key Takeaways
- Qualcomm Ventures led the round alongside Labcorp, Alpha Wave, Blume Ventures, Nexus Venture Partners, and Alteria Capital.
- The $365M valuation is 3x Ultrahuman's $120M mark from 2023; annualized revenue runs at $140M, up 45% year-on-year.
- New Qualcomm silicon will replace cloud processing on the ring; a third-party developer SDK launches on existing units in late September 2026.
Lead
Ultrahuman closed a $70 million Series C on September 3, 2026, with Qualcomm's venture arm leading the syndicate. The Bengaluru-based company - best known for its Ring Air and Ring Pro health trackers - is now explicitly betting that a smart ring can become a programmable, standalone computing device. The round includes $65 million in primary equity and $5 million in debt, valuing Ultrahuman at $365 million, roughly triple its $120 million valuation from 2023.
From Health Tracker to Pocket Computer?
This is not a marketing repositioning. Ultrahuman is switching its core chip from Nordic Semiconductor to Qualcomm silicon, enabling local AI inference instead of cloud offloading. The ring stops being a sensor that ships data to a server and becomes a device that runs algorithms on the finger. Near-term applications include game controller input, car key authentication, and pointer or mouse functionality. A software update arriving on existing Ring Air and Ring Pro units by end of September will unlock these features and open a developer platform so third-party engineers can write their own programs for the device.
Qualcomm's interest is strategic alongside financial. The chipmaker has pushed its silicon into wearables and XR headsets for years. Backing Ultrahuman signals a conviction that rings - cheaper, lighter, and more persistently worn than smartwatches - represent a meaningful frontier for low-power processing. The investment is partly a distribution deal: Qualcomm needs design wins in new form factors, and Ultrahuman needs a chip partner that can handle on-device inference at ring-scale power budgets.
What Does the Business Actually Look Like?
Ultrahuman reported $140 million in annualized revenue, up 45% year-on-year. That growth rate is notable given the headwinds: the company lost U.S. market access for much of the past year after an ITC import ban tied to a patent dispute with rival Oura. The U.S. is the world's largest premium wearables market, and growing 45% without it changes how the trajectory reads once distribution normalizes. The company targets $200 million in annualized revenue by January 2027.
The investor list adds a strategic layer beyond capital. Labcorp, one of the largest U.S. diagnostics companies, joins the cap table alongside financial backers Alpha Wave, Blume Ventures, Nexus Venture Partners, and Alteria Capital. Labcorp's participation points toward clinical-grade health data integration - a direction Ultrahuman has been building toward since launching Blood Vision in July 2025, a service offering blood tests across more than 100 biomarkers tied to ring data.
How Does the Computing Pivot Change the Competitive Picture?
The category is compressing fast. Samsung entered with the Galaxy Ring. Oura holds the lead on brand recognition and volume. Several smaller players have announced products. Every ring now measures sleep quality, heart rate variability, and blood oxygen - the differentiation window on pure health tracking is narrowing. Running software is a different story. If Ultrahuman's developer platform attracts meaningful third-party apps, the ring shifts from hardware product to platform, with the margin implications that accompany the change.
What Needs to Go Right for the $200M Revenue Target?
Two things in parallel: U.S. distribution and developer adoption. If the ITC situation resolves and Ultrahuman re-enters the American market before year-end, the combination of renewed access plus a new computing narrative creates real commercial upside. If distribution problems persist, the revenue target requires sustaining current growth internationally - possible but tighter. On the developer side, the ring-as-computer argument lives or dies by whether engineers actually build for it. A few niche apps turn the narrative into a feature. Broad adoption turns it into a platform.
Outlook
Ultrahuman's $140 million ARR and 45% growth rate justify the $365 million valuation on financial terms independent of the computing bet. The Qualcomm partnership and developer platform are the upside options layered on top. Execution on the September SDK launch and U.S. market re-entry will determine whether the ring-as-computer idea attracts enough developer interest to justify the framing - and, eventually, another larger round. The funding announcement is the easy part.
